Association of PARP inhibitor treatment on the prevalence and progression of clonal hematopoiesis in patients with ...
Poly ADP-ribose polymerase (PARP) inhibitors are approved for the treatment of some men with advanced prostate cancer. Rare but serious side effects include myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML). The impact of PARP inhibitors on …